CannaboTech

Company Overview

Snapshot

Founded in January 2019 by Moav Gafni and Yoav Rothler, CannaboTech operates with 1–10 employees. The company has raised $29 million across four funding rounds. In July 2021, CannaboTech went public on the TASE.

Business overview

CannaboTech develops advanced medical solutions for cancer, inflammation, and chronic pain, utilizing a drug formulation method that combines clinical, botanical qualities. The company focuses on traditional botanical resources to accelerate medicinal development, targeting mainstream consumers seeking innovative and certified medical solutions. CannaboTech has developed its proprietary and patent-pending M²CBD formula, which harnesses cannabinoids and medicinal mushrooms. The company's focus areas include integrative care, preventive medicine, and botanical drugs, operating within the Health Tech & Life Sciences sector.

Strategic signal

In March 2024, CannaboTech secured a significant deal to establish three concept stores for its preventive medicine brand in Thailand. This expansion into Southeast Asia signals a strategic move to broaden its global market presence and capitalize on growing demand for botanical-based health solutions, positioning the company for international growth and market penetration.

Company Intelligence Q&A

When did CannaboTech go public?

CannaboTech went public on the TASE in July 2021.

What was a key finding from CannaboTech's research on colon cancer products?

In March 2022, CannaboTech's "Integrative-Colon" products eliminated over 90% of colon cancer cells in a cell model experiment.

What breakthrough did CannaboTech announce regarding its pancreatic cancer drug?

In July 2022, CannaboTech announced a promising breakthrough in its pancreatic cancer drug, which showed a combined anti-cancer effect between cannabis and mushroom for the first time ever.

What was the outcome of CannaboTech's research on its CannaboBreast products?

In January 2022, research showed CannaboBreast products had a sixfold improvement in killing cancer cells.

What recent international expansion has CannaboTech undertaken?

In March 2024, CannaboTech signed an agreement to establish three concept stores for its preventive medicine brand in Thailand.